Amira Barkal

Dr. Barkal is an innovator, entrepreneur, and leader in the field of immuno-oncology, specifically, in the studies of macrophage regulation and function. At Pheast, she advises on research and development strategy for potential therapies. Dr. Barkal is currently a hematology and medical oncology fellow at University of California, San Francisco. She completed a residency in internal medicine at Brigham and Women’s Hospital at Harvard Medical School. Prior to starting Pheast, she completed her doctoral thesis in the laboratory of Professor Irving Weissman, studying immune regulatory checkpoints in the setting of cancer. She is a recipient of the Ruth L. Kirschstein Fellowship of the National Cancer Institute, the Harold M. Weintraub Award, and the Society of Immunotherapy of Cancer Young Investigator Award. Dr. Barkal received an M.D. and Ph.D. in stem cell biology and regenerative medicine from Stanford University School of Medicine.